In The News

  • Email
  • Print
  • Share
  • Text
Highlight Glossary Terms

  • Dana-Farber physicians including Dr. Barrett Rollins and Dr. Kenneth C. Anderson talked about the next generation of cancer-fighting drugs at the 14th annual Breakfast with the Doctors in Palm Beach.

Tags: Genomics

  • Dr. Steven Treon discussed the game-changing discoveries in Waldenström’s Macroglobulinemia that led to the approval of ibrutinib for treatment of the disease

Tags: Leukemia

  • Drs. Joanne Wolfe, Janet Abrahm, and Susan Block, members of the Pediatric Advanced Care Team - or PACT - at Dana Farber/Boston Children’s Cancer and Blood Disorders Center, commented on the challenges of pediatric palliative care.

Tags: EndOfLife

  • Dr. Joanne Wolfe, director of the Pediatric Advanced Care Team, or PACT, at Dana Farber/Boston Children’s Cancer and Blood Disorders Center, commented on the challenges of pediatric palliative care.

Tags: ChildhoodCancer

  • Dr. James Bradner and his team continue to work on the JQ1 molecule, which tricks the body into forgetting how to make sperm.

Tags: BasicResearch

  • Dr. Kwok-Kin Wong commented on the use of EZH2 inhibitors in lung cancer as needing more rationale in preclinical studies.

Tags: LungCancer

  • Dr. Atul Gawande is among Dana-Farber physicians and patients featured in Frontline’s new film, Being Mortal, which explores the relationships between doctors and patients at the end of life. 

Tags: EndOfLife

  • Dr. Philip Kantoff commented on therapeutic cancer vaccines.

Tags: BasicResearch

  • Dr. Edward J. Benz, Jr. and Dr. Katherine Janeway commented on the benefit of President Obama’s Precision Medicine Initiative that will benefit research at Dana-Farber.

Tags: Genomics, Genetics

  • WCVB-TV reporter and breast cancer survivor Kelley Tuthill is pregnant, and her oncologist, Dr. Ann Partridge, assured her studies show there is no link between pregnancy after successful treatment and recurrence.

Tags: BreastCancer

Showing 21-30 of 529 items